{"nct_id":"NCT01997333","title":"Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer","status":"COMPLETED","status_verified_date":"2019-03","start_date":"2013-11","start_date_type":null,"primary_completion_date":"2017-11-30","primary_completion_date_type":"ACTUAL","completion_date":"2018-08-07","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["CLDX"]}